Community Oncology Alliance inches toward medical home model

medical home - 36.02 Kb
The Community Oncology Alliance (COA) has moved a step forward in its development of an oncology medical home model, recently approving a set of 16 quality measures adhering to guidelines outlined by the National Comprehensive Cancer Network.

“With the measures determined, our next goal will be to develop and promote payment models that reward and promote quality, value and superior outcomes while minimizing administrative and financial burdens,” said Bruce Gould, MD, a COA board member and medical director for the Northwest Georgia Oncology Centers, in a July 18 statement.

The COA, a nonprofit dedicated to advancing cancer patient care, hopes that an effective medical home model will be able to provide more comprehensive, cost-effective, coordinated care for cancer patients.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.